OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director/PDMR Shareholding
Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces that on 14 August 2023 it received notification that Jag Grewal, Chief Executive Officer, had purchased 296,009 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at a price of 2.70 pence each.
A summary of Mr Grewal's resultant holdings is below:
| Director | Board Position | Existing number of Ordinary Shares | Ordinary Shares Purchased | Total beneficial holding of Ordinary Shares following this acquisition | |
| Number of Ordinary Shares | Approximate % of Company's issued share capital | ||||
| Jag Grewal | CEO | 2,164,830 | 296,009 | 2,460,839 | 1.03% |
Contacts:
| Omega Diagnostics Group PLC | |||||
| Jag Grewal, Chief Executive Officer | via Walbrook PR | ||||
| Chris Lea, Chief Financial Officer | | ||||
| | | ||||
| | | ||||
| finnCap Ltd | Tel: 020 7220 0500 | ||||
| Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) | | ||||
| Nigel Birks / Harriet Ward (ECM) | | ||||
| | | ||||
| | | ||||
| Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com | ||||
| Paul McManus / Lianne Applegarth | Mob: 07980 541 893 / 07584 391 303 | ||||
| Sam Allen | Mob: 07502 558 258 | ||||
About Omega Diagnostics Group PLC
Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 85 countries and is now focused on the health and nutrition sector.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Jag Grewal | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Executive Officer | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Omega Diagnostics Group PLC | ||||
| b)
| LEI
| 2138007U9P4BTZTYIR92 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of 4 pence each
ISIN: GB00B1VCP282 | ||||
| b)
| Nature of the transaction
| Ordinary Shares purchased | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
-Aggregated volume
- Price
| See above | ||||
| e)
| Date of the transaction
| 14.08.2023 | ||||
| f)
| Place of the transaction
| London Stock Exchange | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.